Freyia Mahon-Daly

Manchester Academic Health Science Centre

Papers

1

Total Citations

24

H-Index

1

About

Dr. Freyia Mahon-Daly is a leading gynaecological oncologist whose research has fundamentally shaped surgical practice for early-stage cervical cancer. Her landmark 2019 study, "Survival of women with early‐stage cervical cancer in the UK treated with minimal access and open surgery," directly addressed a seismic controversy in the field following paradigm-shifting trials in the New England Journal of Medicine. By analyzing UK outcomes, her work provided critical real-world evidence confirming that women undergoing minimal access radical hysterectomy faced significantly worse survival compared to those receiving open surgery. This contribution, cited 24 times, has been instrumental in re-establishing open surgery as the standard of care and informing critical patient counselling. Dr. Mahon-Daly’s research sits at the intersection of surgical oncology and evidence-based practice, demonstrating how rigorous data analysis can overturn entrenched surgical trends. Her work continues to influence national guidelines and surgical training, ensuring that patient safety remains paramount in the treatment of early-stage cervical cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
24
Total Citations
24
Avg Citations/Paper
🏆 Most Cited Paper
Survival of women with early‐stage cervical cancer in the UK treated with minimal access and open surgery
24 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 23
🏛 Institutions: Manchester Academic Health Science Centre

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago